Actavis

U.K. company Reckitt Benckiser Group plc has delivered the largest M&A deal so far in 2017 by announcing a $19 billion buyout of U.S. company Mead Johnson Nutrition CO (NYSE: MJN). According to CNBC’s Carl Quintanilla, the Mead Johnson buyout is the fourth-largest foreign buyout of a U.S...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) reported better-than-expected results for its fourth quarter, driven by the acquisition of Actavis Generics business. The company also reaffirmed its 2017 outlook, which also came in above consensus expectations. Teva Q4 EPS $1.38 vs $1.35...

Bernstein said the departure of Siggi Olafsson is negative for Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), as investors may fear the move is reflective of deeper malaise. ADRs of Teva were down 3.89 percent in Tuesday’s pre-market hours. Olafsson's Departure Teva announced that...

Oracle Corporation (NYSE: ORCL) announced a massive $14 billion corporate bond sale this week. The company plans on using the proceeds for stock repurchases, dividend payments, debt refinancing and other budget items. While certainly impressive, Oracle’s sale is not even one of the five...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has been in the news a lot lately. Among the potentially unsavory news is the surprise return of CEO Mike Pearson after an extended sick leave, a canceled conference call followed by one-on-one calls to certain bullish analysts, which then raised...

The news of generic challenger for Xifaxan 550mg is brought down the shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX). Though Valeant has adequate patent protection for the drug, the recent news added fuel to the negative investor sentiment on the stock, which has dropped 63 percent in the...

U.S. markets opened in negative territory to start the week following news reports that Japan's economy unexpectedly contracted in the third quarter. U.S. stocks rebounded after the European Central Bank's President Mario Draghi stating that the central bank remains "unanimous in...

U.S. stocks were little changed on Wednesday in another quiet trading session due to a lack of catalysts to move stocks. Economic data showed wholesale inventories rose more than expected in September. Looking forward to Thursday, retail giant Wal-Mart will report earnings before market open...

U.S. stocks were mostly higher after Republicans took control of the Senate after Tuesday's elections as the Dow Jones Industrial Average (INDEXDJX: .DJI) and S&P 500 (INDEXSP: .INX) both closed at historical all-time highs. "Congress will pass some bills I cannot sign; I'm...

U.S. markets were mixed to start the week as the price of crude oil traded at levels it hasn't seen in more than two years following Saudi Arabia's announcement it will cut the selling price of oil to the U.S. and raise prices for other locations. Economic data released today showed...

On Tuesday, the International Monetary Fund reduced its global economic growth forecast for the current year for the ninth time in the past three years. The fund reduced this year’s growth expectation to 3.3 percent and also trimmed its 2015 forecast to 3.4 percent, citing slackening...

U.S. stocks traded lower on Monday ahead of earnings season, which unofficially begins on Wednesday. The Federal Reserve will also release its minutes from its recent meeting on the same day. Major indices were trading in positive territory on Monday with the Dow up as much as 89 points before...

U.S. stocks rose as geopolitical events took a back seat and investors found positives in housing and consumer price index data released Tuesday. The markets followed the lead of Apple which closed at an all-time split-adjusted high of $100.53. Earnings from Home Depot and TJX Companies also...